Skip to content

Effects of Acute Sugar Intake on Choroidal Thickness

Effects of Acute Sugar Intake on Choroidal Thickness

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07376005
Enrollment
47
Registered
2026-01-29
Start date
2026-01-01
Completion date
2026-05-01
Last updated
2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choroid

Brief summary

This study aims to bridge that gap by investigating how acute sugar intake influences choroidal thickness.

Detailed description

This investigation will be a prospective, repeated-measures study. All subjects will arrive fasted and will be asked not to consume any outside food or beverages during the three-hour study period, and will be asked to abstain from caffeine intake for 12 hours before participation. A baseline OCT scan of the macula of the right eye will be performed using the Heidelberg Spectralis OCT system. Participants will then consume 30 grams of sugar in the form of glucose tablets. Macular OCT scans of the right eye will be repeated every 30 minutes for 3 hours following sugar consumption.

Interventions

DIETARY_SUPPLEMENTOral glucose

Participants will consume 30 grams of sugar in the form of glucose tablets.

Sponsors

Southern College of Optometry
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* In order to be eligible for enrolment, each subject must have less than 6 diopters of spherical equivalent refractive error, and have no existing diagnosis of diabetes or pre-diabetes.

Exclusion criteria

* Any potential subject with known retinal pathology will be excluded. Any potential subject with any other known systemic or ocular conditions that may impact their ability to participate in the study or provide generalizable data will also be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Change in choroidal thicknesswithin 3 hours of baselineThe primary outcome for this investigation will be changes in choroidal thickness from baseline across timepoints.

Countries

United States

Contacts

CONTACTMorgan Ollinger, OD, MS
mollinger@sco.edu9017223377

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026